This ticker has not been starred yet COCP Cocrystal Pharma, Inc.
Pharmaceutical Preparations
Book value per $ invested $ 0.79
Leverage 26.58%
Market Cap $ 9.8m
PE 0.00
Dividend Yield 0.00%
Profit $ -9.7m
Margin -9857.98%

Cocrystal Pharma, Inc., a biotechnology company, is focused on the discovery and development of antiviral therapeutic treatments for serious and / or chronic viral diseases. The company is headquartered in Bothell, Washington.

Subscribe Now For Access - Only $1.99 Per Month